European Isotope Program to support targeted radionuclide therapies (TRT) of cancer
Emerging isotopes for TRT promise better therapeutic/theranostic properties, but are lacking availability. A EU counterpart to the US-DOE NIDC should federate the key European neutron sources, accelerators and isotope separation facilities.
Report a problem
Is this content inappropriate?